Clearing the Fog: Dealing with Alzheimer’s disease the Ayurveda way - Dr. Rammohan Rao, PhD
Ram comes from a family of Ayurvedic practitioners and Vedic teachers in India tracing back to the illustrious Vedic-acharya Rishi Kaundinya. Ram completed the academic training at the California College of Ayurveda (CCA) and received his certification as Clinical Ayurvedic Specialist. He serves as a faculty at the California College of Ayurveda in their Nevada city location. Ram is also a dedicated Hatha yoga practitioner and is a RYT from Yoga Alliance USA. Ram has published several articles in major Yoga/Ayurveda journals and has been a featured speaker in several meetings and symposia. He is a member of the National Ayurvedic Medical Association (NAMA), and member of the Association of Ayurvedic Professionals of North America (AAPNA). Ram holds a doctorate degree in Neurosciences and worked as a Research Associate Professor at the Buck Institute for Research on Aging, Novato, CA, on various aspects of age-associated neurodegenerative diseases.
Topic: Clearing the Fog: Dealing with Alzheimer’s disease the Ayurveda way
Alzheimer's disease is an age-associated, progressive neurodegenerative disease that is characterized by severe memory loss, personality changes and an overall decline in cognitive function. The cause of Alzheimer's disease is not yet completely defined and efforts to find a cure for it have so far been disappointing. Ayurveda is a system of traditional medicine native to India and the Indian subcontinent. While a direct reference to Alzheimer’s disease in the ancient Ayurvedic literature is missing, concepts including forgetfulness, memory loss and brain cell loss have been described. Using the clinical information and the metabolic profiling of Alzheimer's disease individuals that was recently reported, we now describe three subtypes based on the Ayurvedic interpretation of Alzheimer's disease. Ayurvedic profiling of Alzheimer's disease will prove to be useful to identify the specific subtype of patients with cognitive decline and those at risk for such decline from the standpoint of specific subtype-based interventions.